UniProt ID | ACE2_HUMAN | |
---|---|---|
UniProt AC | Q9BYF1 | |
Protein Name | Angiotensin-converting enzyme 2 | |
Gene Name | ACE2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 805 | |
Subcellular Localization |
Processed angiotensin-converting enzyme 2: Secreted. Cell membrane Single-pass type I membrane protein. Cytoplasm. Detected in both cell membrane and cytoplasm in neurons.. |
|
Protein Description | Carboxypeptidase which converts angiotensin I to angiotensin 1-9, a peptide of unknown function, and angiotensin II to angiotensin 1-7, a vasodilator. Also able to hydrolyze apelin-13 and dynorphin-13 with high efficiency. May be an important regulator of heart function.; (Microbial infection) Acts as a receptor for SARS coronavirus/SARS-CoV.; (Microbial infection) Acts as a receptor for Human coronavirus NL63/HCoV-NL63.. | |
Protein Sequence | MSSSSWLLLSLVAVTAAQSTIEEQAKTFLDKFNHEAEDLFYQSSLASWNYNTNITEENVQNMNNAGDKWSAFLKEQSTLAQMYPLQEIQNLTVKLQLQALQQNGSSVLSEDKSKRLNTILNTMSTIYSTGKVCNPDNPQECLLLEPGLNEIMANSLDYNERLWAWESWRSEVGKQLRPLYEEYVVLKNEMARANHYEDYGDYWRGDYEVNGVDGYDYSRGQLIEDVEHTFEEIKPLYEHLHAYVRAKLMNAYPSYISPIGCLPAHLLGDMWGRFWTNLYSLTVPFGQKPNIDVTDAMVDQAWDAQRIFKEAEKFFVSVGLPNMTQGFWENSMLTDPGNVQKAVCHPTAWDLGKGDFRILMCTKVTMDDFLTAHHEMGHIQYDMAYAAQPFLLRNGANEGFHEAVGEIMSLSAATPKHLKSIGLLSPDFQEDNETEINFLLKQALTIVGTLPFTYMLEKWRWMVFKGEIPKDQWMKKWWEMKREIVGVVEPVPHDETYCDPASLFHVSNDYSFIRYYTRTLYQFQFQEALCQAAKHEGPLHKCDISNSTEAGQKLFNMLRLGKSEPWTLALENVVGAKNMNVRPLLNYFEPLFTWLKDQNKNSFVGWSTDWSPYADQSIKVRISLKSALGDKAYEWNDNEMYLFRSSVAYAMRQYFLKVKNQMILFGEEDVRVANLKPRISFNFFVTAPKNVSDIIPRTEVEKAIRMSRSRINDAFRLNDNSLEFLGIQPTLGPPNQPPVSIWLIVFGVVMGVIVVGIVILIFTGIRDRKKKNKARSGENPYASIDISKGENNPGFQNTDDVQTSF | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MSSSSWLLL ------CCCHHHHHH | 38.64 | 46157543 | |
10 | Phosphorylation | SSSWLLLSLVAVTAA CHHHHHHHHHHHHHH | 22.29 | 46157537 | |
20 | Phosphorylation | AVTAAQSTIEEQAKT HHHHHHHHHHHHHHH | 21.96 | 29116813 | |
27 | Phosphorylation | TIEEQAKTFLDKFNH HHHHHHHHHHHHCCH | 32.23 | 29116813 | |
53 | N-linked_Glycosylation | ASWNYNTNITEENVQ HHCCCCCCCCHHHHH | 35.23 | 14754895 | |
90 | N-linked_Glycosylation | YPLQEIQNLTVKLQL CCHHHHHHHHHHHHH | 43.25 | 15084671 | |
103 | N-linked_Glycosylation | QLQALQQNGSSVLSE HHHHHHHCCCCCCCC | 39.08 | 14754895 | |
128 | Phosphorylation | NTMSTIYSTGKVCNP HHHHHHHHCCCCCCC | 27.17 | 68717163 | |
129 | Phosphorylation | TMSTIYSTGKVCNPD HHHHHHHCCCCCCCC | 24.85 | 68717169 | |
322 | N-linked_Glycosylation | FVSVGLPNMTQGFWE HHHCCCCCCCCCCHH | 51.69 | 14754895 | |
432 | N-linked_Glycosylation | SPDFQEDNETEINFL CCCCCCCCHHHHHHH | 58.29 | 14754895 | |
449 | Phosphorylation | QALTIVGTLPFTYML HHHHHHHCCCHHHHH | 21.99 | 22210691 | |
453 | Phosphorylation | IVGTLPFTYMLEKWR HHHCCCHHHHHHHEE | 13.19 | 22210691 | |
545 | Phosphorylation | PLHKCDISNSTEAGQ CCCCCCCCCCCHHHH | 16.10 | 51457809 | |
546 | N-linked_Glycosylation | LHKCDISNSTEAGQK CCCCCCCCCCHHHHH | 53.97 | 14754895 | |
547 | Phosphorylation | HKCDISNSTEAGQKL CCCCCCCCCHHHHHH | 22.34 | 51457815 | |
548 | Phosphorylation | KCDISNSTEAGQKLF CCCCCCCCHHHHHHH | 33.82 | 51457821 | |
625 | Ubiquitination | IKVRISLKSALGDKA EEEEEEHHHHHCCCE | 27.22 | 33845483 | |
676 | Ubiquitination | DVRVANLKPRISFNF CEEECCCCCCEEEEE | 31.86 | 29967540 | |
690 | N-linked_Glycosylation | FFVTAPKNVSDIIPR EEEECCCCHHHCCCH | 37.15 | UniProtKB CARBOHYD | |
692 | Phosphorylation | VTAPKNVSDIIPRTE EECCCCHHHCCCHHH | 32.27 | 46157549 | |
702 | Ubiquitination | IPRTEVEKAIRMSRS CCHHHHHHHHHHHHH | 55.05 | 33845483 | |
770 | Acetylation | TGIRDRKKKNKARSG HCCCCHHHHCCCCCC | 63.57 | 2520697 | |
771 | Acetylation | GIRDRKKKNKARSGE CCCCHHHHCCCCCCC | 67.71 | 2520705 | |
773 | Acetylation | RDRKKKNKARSGENP CCHHHHCCCCCCCCC | 54.80 | 2520713 | |
776 | Phosphorylation | KKKNKARSGENPYAS HHHCCCCCCCCCCCE | 56.15 | 28857561 | |
781 | Phosphorylation | ARSGENPYASIDISK CCCCCCCCCEEECCC | 25.27 | 26657352 | |
783 | Phosphorylation | SGENPYASIDISKGE CCCCCCCEEECCCCC | 18.23 | 26657352 | |
787 | Phosphorylation | PYASIDISKGENNPG CCCEEECCCCCCCCC | 30.75 | 28442448 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
787 | S | Phosphorylation | Kinase | CK2A1 | P68400 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
90 | N | Glycosylation |
| 15084671 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ACE2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
ANGT_HUMAN | AGT | physical | 10969042 | |
ANGT_HUMAN | AGT | physical | 15283675 | |
ACE2_HUMAN | ACE2 | physical | 16166518 | |
CATA_HUMAN | CAT | physical | 26344197 | |
INO1_HUMAN | ISYNA1 | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"ACE2 X-ray structures reveal a large hinge-bending motion importantfor inhibitor binding and catalysis."; Towler P., Staker B., Prasad S.G., Menon S., Tang J., Parsons T.,Ryan D., Fisher M., Williams D., Dales N.A., Patane M.A.,Pantoliano M.W.; J. Biol. Chem. 279:17996-18007(2004). Cited for: X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 19-615, X-RAY CRYSTALLOGRAPHY(3.0 ANGSTROMS) OF 19-615 IN COMPLEX WITH MLN-4760, DISULFIDE BONDS,AND GLYCOSYLATION AT ASN-53; ASN-90; ASN-103; ASN-322; ASN-432 ANDASN-546. | |
"Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-546, AND MASSSPECTROMETRY. | |
"A proteomic analysis of human bile."; Kristiansen T.Z., Bunkenborg J., Gronborg M., Molina H.,Thuluvath P.J., Argani P., Goggins M.G., Maitra A., Pandey A.; Mol. Cell. Proteomics 3:715-728(2004). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-90, AND MASS SPECTROMETRY. |